{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    15,
    27
  ],
  "modelUsed": "gemini-3-flash-preview",
  "advanced": {
    "studyAmendments": [
      {
        "id": "amend_1",
        "number": "1",
        "name": "Amendment 1",
        "scope": {
          "id": "a2dbb43b-d4e5-4978-bbab-96803b712b29",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "3f254475-e888-4f6c-a7f5-6cea82c1b035",
          "code": {
            "id": "8f25097e-86d2-4af1-9d6f-b6bb63fea7b1",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "8ef42b4f-5155-4edc-a579-ac18304f7e02",
            "type": {
              "id": "93605c5c-1f01-43f3-9fa1-34a25f201665",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "The main reason for preparation of this amendment was to update the inclusion criteria to allow for a broader range of NT-proBNP levels based on atrial fibrillation status and to clarify the use of background heart failure medications.",
        "effectiveDate": "2017-02-15",
        "reasonIds": [
          "ar_1_1",
          "ar_1_2"
        ],
        "previousVersion": "Original Protocol",
        "newVersion": "1.0"
      },
      {
        "id": "amend_2",
        "number": "2",
        "name": "Amendment 2",
        "scope": {
          "id": "da08cb22-ed80-4ac3-9fcd-c27945548ee9",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "6be674a8-b9d6-4d80-9e72-58191278d787",
          "code": {
            "id": "2ce27352-a515-412a-953a-17b905c10d12",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "3a957437-a2b1-4595-9093-dcd8a07e64f7",
            "type": {
              "id": "8214848e-6b7c-454c-82f1-16fd0bada159",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "The main reason for preparation of this amendment was to increase the sample size from 2850 to up to 4000 patients if accumulated blinded data suggested slower accrual of primary outcome events, and to refine the renal endpoint definitions.",
        "effectiveDate": "2018-08-31",
        "reasonIds": [
          "ar_2_1",
          "ar_2_2"
        ],
        "previousVersion": "1.0",
        "newVersion": "2.0"
      },
      {
        "id": "amend_3",
        "number": "3",
        "name": "Amendment 3",
        "scope": {
          "id": "6ca10505-a8ab-478c-aaa0-c9218c09a212",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "15ae2f9b-01bd-4a52-8723-385e8eb381d3",
          "code": {
            "id": "8693d5e7-b9c7-4275-b779-be94e983e097",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "c72b9e1f-2764-4b58-af60-eba70c3eb22f",
            "type": {
              "id": "c9b28528-f37a-49d4-93a1-6a68d5580d7f",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "The main reason for preparation of this amendment was to update the administrative structure of the trial, refine the adjudication process for heart failure hospitalizations, and adjust the follow-up period to ensure the target number of 841 primary outcome events is achieved.",
        "effectiveDate": "2019-11-20",
        "reasonIds": [
          "ar_3_1",
          "ar_3_2",
          "ar_3_3"
        ],
        "previousVersion": "2.0",
        "newVersion": "4.0"
      }
    ],
    "amendmentReasons": [
      {
        "id": "ar_1_1",
        "code": "SCIENTIFIC",
        "description": "Scientific",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_1_2",
        "code": "OPERATIONAL",
        "description": "Operational",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_1",
        "code": "SCIENTIFIC",
        "description": "Scientific",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_2",
        "code": "STATISTICAL",
        "description": "Statistical",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_3_1",
        "code": "ADMINISTRATIVE",
        "description": "Administrative",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_3_2",
        "code": "OPERATIONAL",
        "description": "Operational",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_3_3",
        "code": "STATISTICAL",
        "description": "Statistical",
        "instanceType": "AmendmentReason"
      }
    ],
    "countries": [],
    "studySites": [],
    "summary": {
      "amendmentCount": 3,
      "countryCount": 0,
      "siteCount": 0
    },
    "geographicScope": {
      "id": "geo_1",
      "name": "Study Geographic Scope",
      "scopeType": "Global",
      "instanceType": "GeographicScope"
    }
  },
  "rawResponse": {
    "amendments": [
      {
        "number": "1",
        "effectiveDate": "2017-02-15",
        "summary": "The main reason for preparation of this amendment was to update the inclusion criteria to allow for a broader range of NT-proBNP levels based on atrial fibrillation status and to clarify the use of background heart failure medications.",
        "previousVersion": "Original Protocol",
        "newVersion": "1.0",
        "reasons": [
          "Scientific",
          "Operational"
        ]
      },
      {
        "number": "2",
        "effectiveDate": "2018-08-31",
        "summary": "The main reason for preparation of this amendment was to increase the sample size from 2850 to up to 4000 patients if accumulated blinded data suggested slower accrual of primary outcome events, and to refine the renal endpoint definitions.",
        "previousVersion": "1.0",
        "newVersion": "2.0",
        "reasons": [
          "Scientific",
          "Statistical"
        ]
      },
      {
        "number": "3",
        "effectiveDate": "2019-11-20",
        "summary": "The main reason for preparation of this amendment was to update the administrative structure of the trial, refine the adjudication process for heart failure hospitalizations, and adjust the follow-up period to ensure the target number of 841 primary outcome events is achieved.",
        "previousVersion": "2.0",
        "newVersion": "4.0",
        "reasons": [
          "Administrative",
          "Operational",
          "Statistical"
        ]
      }
    ],
    "geographicScope": {
      "type": "Global",
      "countries": [],
      "regions": [],
      "plannedSites": 15
    },
    "sites": []
  }
}